Literature DB >> 6993564

Polyclonal activation of human lymphocytes in vitro-II. Reappraisal of T and B cell-specific mitogens.

H M Dosch, R K Schuurman, E W Gelfand.   

Abstract

The capacity of the T cell mitogens phytohemagglutinin (PHA), concanavalin A (Con A), pokeweed mitogen (PWM), and Staphylococcus protein A (SpA) to induce B cell proliferation and differentiation was compared with the B cell mitogen, formalinized Staphylococcus aureus (STA). Lymphocyte subpopulations from normal donors and patients with various immunodeficiency diseases were studied. In the presence of the T cell mitogens, irradiated T cells were capable of providing a helper cell activity that enabled co-cultured B lymphocytes to proliferate in response to these mitogens and to differentiate into IgM-secreting (direct) hemolytic plaque-forming cells (PFC). In the PFC response, radioresistant T-helper and radiosensitive T-suppressor cell activities could be demonstrated. T-suppressor cell activity outweighed helper activity only in nonirradiated co-cultures stimulated with Con A. Patients with severe combined immunodeficiency lacked mitogen-induced helper T cells, whereas patients with various forms of humoral immune deficiency were normal in this respect. These findings and the tissue distribution of the helper activity is aquired early in post-thymic T cell differentiation. The data suggest that experiments with cell lineage-specific lymphocyte mitogens should be considered in the context of more complex cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993564

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Early diagnosis in X-linked agammaglobulinaemia.

Authors:  R K Schuurman; E J Mensink; L A Sandkuyl; E D Post; H van Velzen-Blad
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial.

Authors:  David Hadley; Roy K Cheung; Dorothy J Becker; Rose Girgis; Jerry P Palmer; David Cuthbertson; Jeffrey P Krischer; Hans-Michael Dosch
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

4.  Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate.

Authors:  C M Hawrylowicz; G G Klaus
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

5.  Cord blood B cell differentiation. Synergistic effect of pokeweed mitogen and Staphylococcus aureus on in vitro differentiation of B cells from human neonates.

Authors:  K M Miller; W B Pittard; R U Sorensen
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

6.  Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.

Authors:  T Nakamura; N Miyasaka; R M Pope; N Talal; I J Russell
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

7.  In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I: evidence for the role of Leu-2-positive T suppressor cells and radiosensitive T helper cells.

Authors:  R Goldstein; L Perelmutter; J Karsh
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

8.  Monocytes are required to trigger Ca2+ uptake in the proliferative response of human t lymphocytes to staphylococcus aureus protein A.

Authors:  H M Lederman; J W Lee; R K Cheung; S Grinstein; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes.

Authors:  E L Morgan; W O Weigle
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.